| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |